BR-body mutant mRNA half-life profiling.
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
BR-body mutant strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. JS38 (wild type) was compared to JS221 (lacking the intrinsically disordered CTD and unable to form BR-bodies), JS233 (unable to recruit degradosome components into BR-bodies), and JS299 (active site mutant of RNase E). BR-body mutant strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. Biological samples were taken before treatment, then at 1, 3, and 9 minutes after rifampicin treatment.
创建时间：
2019-07-07
